• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sp1 缺陷对 I 型转化生长因子-β 受体启动子表达的抑制作用

Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.

作者信息

Periyasamy S, Ammanamanchi S, Tillekeratne M P, Brattain M G

机构信息

Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo 43614, USA.

出版信息

Oncogene. 2000 Sep 21;19(40):4660-7. doi: 10.1038/sj.onc.1203822.

DOI:10.1038/sj.onc.1203822
PMID:11030155
Abstract

In this report, we describe the mechanism of TGF-beta receptor type I (RI) repression in the GEO human colon carcinoma cells. Treatment of GEO cells with the DNA methyltransferase inhibitor, 5 azacytidine induced RI expression and restored TGF-beta response. A stably transfected RI promoter-reporter construct (RI-Luc) expressed higher activity in the 5 aza C treated GEO cells, suggesting the activation of a transactivator for RI transcription. Gel shift analysis indicated enhanced binding of proteins from the 5 aza C treated nuclear extracts to radiolabeled Sp1 oligonucleotides specifically contained in the RI promoter. Protein stability studies after cyclohexamide treatment suggested an increase in the Sp1 protein stability from the 5 aza C treated GEO cells. Further, transfection of Sp1 cDNA into untreated GEO control cells increased RI promoter activity and thus induced RI expression. 5 aza C mediated Sp1 expression in Sp1 deficient GEO colon and MCF-7 breast cancer cells also enhanced the activity of several other Sp1 dependent promoters such as TGF-beta receptor type II (RII), Cyclin A and p21/waf1/cip1. These results indicate that restoration of Sp1 in several different types of Sp1 deficient cells leads to enhanced activation of a wide range of Sp1 dependent promoters.

摘要

在本报告中,我们描述了GEO人结肠癌细胞中转化生长因子βⅠ型受体(RI)抑制的机制。用DNA甲基转移酶抑制剂5-氮杂胞苷处理GEO细胞可诱导RI表达并恢复转化生长因子β反应。一个稳定转染的RI启动子-报告基因构建体(RI-Luc)在经5-氮杂胞苷处理的GEO细胞中表现出更高的活性,提示存在一种RI转录反式激活因子被激活。凝胶迁移分析表明,来自经5-氮杂胞苷处理的细胞核提取物中的蛋白质与RI启动子中特有的放射性标记的Sp1寡核苷酸的结合增强。环己酰亚胺处理后的蛋白质稳定性研究表明,经5-氮杂胞苷处理的GEO细胞中Sp1蛋白的稳定性增加。此外,将Sp1 cDNA转染入未处理的GEO对照细胞可增加RI启动子活性,从而诱导RI表达。5-氮杂胞苷在Sp1缺陷的GEO结肠癌细胞和MCF-7乳腺癌细胞中介导的Sp1表达还增强了其他几种Sp1依赖性启动子的活性,如转化生长因子βⅡ型受体(RII)、细胞周期蛋白A和p21/waf1/cip1。这些结果表明,在几种不同类型的Sp1缺陷细胞中恢复Sp1可导致多种Sp1依赖性启动子的激活增强。

相似文献

1
Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.Sp1 缺陷对 I 型转化生长因子-β 受体启动子表达的抑制作用
Oncogene. 2000 Sep 21;19(40):4660-7. doi: 10.1038/sj.onc.1203822.
2
Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.法尼基转移酶抑制剂(L-744,832)可恢复转化生长因子-β II型受体表达,并增强K-ras突变型胰腺癌细胞系MIA PaCa-2的辐射敏感性。
Oncogene. 2002 Nov 7;21(51):7883-90. doi: 10.1038/sj.onc.1205948.
3
Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.通过5-氮杂-2'-脱氧胞苷激活SP1诱导雌激素受体阳性乳腺癌细胞中II型转化生长因子-β受体表达
J Biol Chem. 1998 Jun 26;273(26):16527-34. doi: 10.1074/jbc.273.26.16527.
4
Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.5-氮杂-2'-脱氧胞苷逆转Sp1的转录抑制作用可恢复胰腺癌细胞系MIA PaCa-2中转化生长因子-β II型受体的表达。
Cancer Res. 2001 Aug 15;61(16):6239-47.
5
Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸(SAHA)通过Sp1位点激活不依赖p53的p21WAF1/CIP1启动子。
Oncogene. 2000 Nov 23;19(50):5712-9. doi: 10.1038/sj.onc.1203963.
6
Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.组蛋白去乙酰化酶介导的人胰腺癌细胞中转化生长因子β II型受体表达抑制对特定Sp1位点的需求。
Cancer Res. 2003 May 15;63(10):2624-30.
7
Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.转化生长因子β受体在人胰腺腺癌中的差异表达
Anticancer Res. 2000 Jan-Feb;20(1A):43-51.
8
Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.人乳腺癌MCF-7细胞中转化生长因子-βⅡ型受体的表达与致瘤性
J Cell Physiol. 1998 Aug;176(2):424-34. doi: 10.1002/(SICI)1097-4652(199808)176:2<424::AID-JCP21>3.0.CO;2-1.
9
Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.新型Sp1位点对人转化生长因子βⅡ型受体基因启动子的调控
Oncogene. 2001 Oct 18;20(47):6899-909. doi: 10.1038/sj.onc.1204808.
10
5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.5-氮杂胞苷处理通过下调Sp3增强转化生长因子-β受体的表达。
J Biol Chem. 2001 Aug 31;276(35):32854-9. doi: 10.1074/jbc.M103951200. Epub 2001 Jul 6.

引用本文的文献

1
Ex Vivo Human Colon Tissue Exposure to Pristine Graphene Activates Genes Involved in the Binding, Adhesion and Proliferation of Epithelial Cells.离体人结肠组织暴露于原始石墨烯中可激活涉及上皮细胞结合、黏附和增殖的基因。
Int J Mol Sci. 2021 Oct 23;22(21):11443. doi: 10.3390/ijms222111443.
2
Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.FBXO32 在结直肠肿瘤中的作用研究——转化生长因子β(TGF-β)/Smad4 信号通路
Med Sci Monit. 2018 Feb 21;24:1080-1088. doi: 10.12659/msm.908030.
3
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins.
检测乳腺癌患者中 DNA 甲基转移酶的表达,并分析天然化合物对 DNA 甲基转移酶和相关蛋白的影响。
J Breast Cancer. 2013 Mar;16(1):23-31. doi: 10.4048/jbc.2013.16.1.23. Epub 2013 Mar 31.
4
Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma.胃贲门腺癌中转化生长因子-β信号通路基因的一致性抑制和异常甲基化发生较早。
Mol Biol Rep. 2012 Oct;39(10):9453-62. doi: 10.1007/s11033-012-1810-x. Epub 2012 Jun 22.
5
DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.DNA 甲基转移酶抑制剂,泽布替尼,可延缓乳腺癌基因工程小鼠模型中的肿瘤生长并诱导细胞凋亡。
Mol Cancer Ther. 2012 Feb;11(2):370-82. doi: 10.1158/1535-7163.MCT-11-0458. Epub 2011 Dec 27.
6
Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death.组蛋白去乙酰化酶抑制剂贝林司他通过重新激活转化生长因子 β(TGFβ)受体 II 抑制存活素的表达,从而导致癌细胞死亡。
J Biol Chem. 2011 Sep 2;286(35):30937-30948. doi: 10.1074/jbc.M110.212035. Epub 2011 Jul 8.
7
Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer.鉴定新型 TGFβ/PKA 信号转导组在调控结肠癌细胞存活和转移中的作用。
PLoS One. 2011 May 3;6(5):e19335. doi: 10.1371/journal.pone.0019335.
8
Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta.转化生长因子-β信号通路基因在人骨关节炎软骨细胞中的调控:Sp1 在转化生长因子-β早期和晚期反应细胞中均有参与。
Arthritis Res Ther. 2011 Feb 15;13(1):R23. doi: 10.1186/ar3247.
9
Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy.转化生长因子β受体II的表观遗传靶向作用及其对癌症治疗的意义。
Mol Cell Pharmacol. 2009 Jan 1;1(1):57-70. doi: 10.4255/mcpharmacol.09.07.
10
Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.人乳头瘤病毒16型介导的转化后期I型转化生长因子-β受体表达降低的机制
Cancer Lett. 2009 Sep 18;282(2):177-86. doi: 10.1016/j.canlet.2009.03.014. Epub 2009 Apr 2.